>
Google Leaks: Censorship Exposed
Great Food Reset - Meat rationing has arrived!
Are The "Barbarians" Already Here?
Insulin-free life for diabetics closer after successful cell pouch trial
[Tesla] AI Revolution: Robot Workers, Supercomputer Demands, & Mind-Blowing Designs!
Aviation Week Believes Secret SR-72 Plane is in Production at Lockheed Martin
"Suspended animation" drug could buy time in medical emergencies
Simple technique removes over 98% of nanoplastic particles from water
We are Being Tracked on the Internet Via Our Phone Number! Zero Anonymity
What Can Solve the Huge Energy Demands of a Future with Abundant AI?
Mosquitoes can fly but they can't hide from the Bzigo Iris
Nuclear waste powered battery produces thousands of years of clean energy
Known as "histotripsy," the method and machinery have already been tested successfully in animals and humans, and has just been approved for use by the FDA.
HistoSonics is a company founded in 2009 to create an ultrasound device that both screens for tumors and administers histotripsy. It was born from the efforts of scientists at the University of Michigan who co-founded the firm.
"Histotripsy is an exciting new technology that, although it is in early stages of clinical use, may provide a noninvasive treatment option for patients with liver cancer. Hopefully it can be combined with systemic therapies for a synergistic therapeutic effect," said Mishal Mendiratta-Lala, professor of radiology with Michigan Medicine.
Mendiratta-Lala was the principal investigator of an FDA human trial started in 2021 which confirmed that HistoSonic's device, called Edison, can destroy cancer tumors.